Zahinoor Ismail, MD

  • 9Articles
  • 59KReads1
  • 2018–2022Active
  • 47Collaborators
  • 259Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Zahinoor Ismail, MD, has published extensively on patient functioning and life engagement as treatment goals in major depressive disorder and schizophrenia. The work also addresses unmet needs in these conditions, as well as the prevalence and clinical correlates of mild behavioral impairment and dementia risk, particularly in Asian populations. Additional research includes symptomatic and functional outcomes related to pharmacotherapy in major depressive disorder and the prevalence of depression among older adults with dementia.

Publications

JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
Insights

Patient Functioning and Life Engagement: Treatment Goals in MDD

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...
, , , et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder
Academic Highlights

Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...
, , , et al
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
Insights

Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
, , , et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
Academic Highlights

Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
, , , et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Insights

Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia

August 8, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
, , , et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Academic Highlights

Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia

August 3, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
, , , et al
JCP
Cognitive Trajectories of MBI
Original Research

Cognitive Trajectories of MBI

March 16, 2022

The diagnostic construct of mild behavioral impairment (MBI), proposed to identify an at-risk group for dementia, has been studied mostly in Western populations. This study investigated the epidemiologic characteristics...
, , , et al
JCP
Original Research

CAN-BIND-1 Outcomes and Early Response Prediction in MDD

February 5, 2019

Antidepressant medications are often prescribed with little certainty about their potential effectiveness in individual patients. Can early symptom reduction help predict later symptomatic and functional outcomes of antidepressant treatment?...
, , , et al
JCP
Meta-Analysis

MDD in Older Adults with Dementia

July 31, 2018

Read a meta-analysis explores the prevalence of MDD in all causes of dementia and diagnostic criteria when finding these disorders.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe